Showing results (1431-1440 of 1,501) with videos related to

Sort By:
Pageof 151
Oncotarget|April 13, 2018
The long non-coding RNA <i>HOTAIR</i> is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant gliomaAna Xavier-Magalhães, Céline S Gonçalves, Anne Fogli, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|May 11, 2023
Comparative biochemical and molecular responses of biotransformation and antioxidant systems in three species of Crassostrea (Sacco, 1897) oysters exposed to chryseneCamila L V Bastolla, Daína Lima, Jacó J Mattos, et al.
Fertility and Sterility|August 13, 2018
Skewed X-chromosome inactivation and shorter telomeres associate with idiopathic premature ovarian insufficiencyCristiana L Miranda-Furtado, Heloise R Luchiari, Daiana C Chielli Pedroso, et al.
Journal of Neuroendocrinology|October 28, 2022
Norepinephrine modulation of heat dissipation in female rats lacking estrogenCristina S Fonseca, Nayara S S Aquino, Gleisy K N Goncalves, et al.
Biotechnology Reports (Amsterdam, Netherlands)|March 30, 2017
Identification of oxidoreductases from the petroleum <i>Bacillus safensis</i> strainFrancine S A da Fonseca, Célio F F Angolini, Marco A Zezzi Arruda, et al.
The Journal of Pathology|June 2, 2006
EGFR amplification and lack of activating mutations in metaplastic breast carcinomasJ S Reis-Filho, C Pinheiro, M B K Lambros, et al.
Prostate Cancer and Prostatic Diseases|September 27, 2024
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS scoreHelen Y Hougen, Isildinha M Reis, Sunwoo Han, et al.
The Journal of Urology|December 28, 2020
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted BiopsySanoj Punnen, Radka Stoyanova, Deukwoo Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivoFiona Simpkins, Pedro Hevia-Paez, Jun Sun, et al.
JAMA Network Open|October 8, 2024
Reproductive Risk Factor Patterns in Caribbean Women With Breast Cancer Across 4 GenerationsAlex P Sanchez-Covarrubias, Maurice J Chery, Priscilla Barreto-Coehlo, et al.
Pageof 151